Trade

Innova Captab share price

Balanced risk
  • 33%Low risk
  • 33%Moderate risk
  • 33%Balanced risk
  • 33%High risk
  • 33%Extreme risk
  • 725.45(-0.10%)
    December 12, 2025 15:25:21 PM IST
    • NSE
    • BSE
  • Vol : 32.02 K (NSE + BSE)
    Last 20 day avg : 32.06 K

Innova Captab is trading -0.10% lower at Rs 725.45 as compared to its last closing price. Innova Captab has been trading in the price range of 732.00 & 708.80. Innova Captab has given -35.01% in this year & 1.84% in the last 5 days. There are 2 analysts who have initiated coverage on Innova Captab. There are 0.00 analysts who have given it a strong buy rating & 2 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of 29.67 Crores in its last quarter.Listed peers of Innova Captab include Torrent Pharmaceuticals (-0.56%), Dr Reddy's Laboratories (0.51%), Sun Pharmaceutical Industries (-0.69%).The Mutual Fund holding in Innova Captab was at 10.69% in 30 Sep 2025. The MF holding has increased from the last quarter. The FII holding in Innova Captab was at 0.08% in 30 Sep 2025. The FII holding has decreased from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Explore on
Loading...
Key Metrics

Updated on Dec 13, 2025, 12:37 PM UTC

  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.00
    Lower than industry
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    1.76
    Indicates Fair Valuation
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    -
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    -
  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    -
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    -
Price range
Day Range
Lowest
708.80
Highest
732.00
52 week range
Lowest
655.15
Highest
1,259.00
Innova Captab Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Torrent Pharmaceuticals
Bullish
3,780.00-0.561,27,870.0566.6416.920.8417.62
Dr Reddy's Laboratories
Bullish
1,279.500.511,06,784.7818.803.170.632.34
Sun Pharmaceutical Industries
Bullish
1,794.50-0.694,30,478.6837.946.040.880.50
Cipla
Neutral
1,515.150.201,22,397.5523.333.940.850.81
Divi's Laboratories
Bullish
6,414.50-0.271,70,282.1778.2711.470.460.01
Mutual Fund Ownership
View all
Kotak Healthcare Fund Regular Growth
NA
  • Amount Invested (Cr.) 8.09
  • % of AUM 1.86
Kotak Consumption Fund Regular Growth
NA
  • Amount Invested (Cr.) 19.32
  • % of AUM 1.55
Canara Robeco Manufacturing Fund Regular Growth
NA
  • Amount Invested (Cr.) 23.92
  • % of AUM 1.47
Edelweiss Recently Listed IPO Fund Regular Plan Growth
NA
  • Amount Invested (Cr.) 11.42
  • % of AUM 1.28
Canara Robeco Small Cap Fund Regular Growth
2/5
  • Amount Invested (Cr.) 142.32
  • % of AUM 1.15
Innova Captab Corporate Actions
View all
  • Board Meetings
  • AGM
  • Dividends
  • Bonus
  • Split
  • Rights
Meeting DatePurpose
2025-11-07Quarterly Results
2025-08-07Quarterly Results
2025-05-19Audited Results
2025-02-05Quarterly Results & Others
2024-11-07Quarterly Results
About the company Innova Captab
  • IndustryBiotechnology & Drugs
  • ISININE0DUT01020
  • BSE Code544067
  • NSE CodeINNOVACAP
Innova Captab Limited is an integrated pharmaceutical company. The Company is engaged in the business of manufacturing and trading of drugs and pharmaceuticals. It has a presence across the pharmaceuticals value chain, including research and development, manufacturing, drug distribution and marketing and exports. Its business includes Contract Development and Manufacturing (CDMO) Services and Products, Domestic Branded Generics, and International Branded Generics. Its CDMO business provides research, product development and manufacturing services. Its Branded Generics business consists of the development, manufacture and distribution of generic formulation products, which are marketed and distributed in India under its own brand names through online and offline channels. Its generic drug products are also available online through various e-commerce pharmacy sites. It has developed a diversified branded generics product portfolio including tablets, capsules, dry syrups, and others.
  • Management Info
  • Lokesh BhasinChief Financial Officer
  • Neeharika ShuklaCompliance Officer, Company Secretary
  • Vinay LohariwalaManaging Director
  • Manoj LohariwalaWhole-Time Director
  • Jayant RaoWhole-Time Director
Innova Captab Share Price FAQs

Innova Captab is trading at 725.45 as on Fri Dec 12 2025 09:55:21. This is -0.10% lower as compared to its previous closing price of 726.15.

The market capitalization of Innova Captab is 4151.38 Cr as on Fri Dec 12 2025 09:55:21.

The average broker rating on Innova Captab is Buy. The breakup of analyst rating is given below -

  • 0.00 analysts have given a strong buy rating
  • 2 analysts have given a buy rating
  • 0.00 analysts have given a hold rating
  • 0.00 analysts have given a sell rating
  • 0.00 analysts have given a strong sell rating

The 52 wk high for Innova Captab is 1259.00 whereas the 52 wk low is 655.15

Innova Captab can be analyzed on the following key metrics -

  • TTM P/E: 39.25
  • Sector P/E: -
  • Dividend Yield: 0.00%
  • D/E ratio: 0.33

Innova Captab reported a net profit of 128.26 Cr in 2025.

The Mutual Fund Shareholding was 10.69% at the end of 30 Sep 2025.